Burden and Impact of Frailty and Comorbidity in Individuals Screened for Lung Cancer
Our novel finding that the majority of screened individuals had a low predicted probability of frailty provides some reassurance that few individuals with screen-detected lung cancer may be unable to undergo treatment based on frailty criteria.
Authors
- Danielle D. Durham (ORCID: https://orcid.org/0000-0002-8871-589X)
- Louise M. Henderson (ORCID: https://orcid.org/0000-0001-8356-9267)
- Lindsay Lane (ORCID: https://orcid.org/0000-0003-4361-3109)
- Daniel S. Reuland (ORCID: https://orcid.org/0000-0002-7839-6581)
- C.D. Baggett (ORCID: https://orcid.org/0000-0002-9563-203X)
- Jennifer L. Lund (ORCID: https://orcid.org/0000-0002-1108-0689)
- M. Patricia Rivera (ORCID: https://orcid.org/0000-0003-3827-5010)
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Rochester Medical Center (US)
- University of Rochester (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-1099
- Primary Topic
- Frailty in Older Adults
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute
- National Center for Advancing Translational Sciences
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill